
We found 2 result(s) that match your search "Exubera":
Search Results
Well, it is official. The inhaled insulin
Exubera is being pulled from the market by Pfizer. An ADA
article reports that Pfizer took a $2.8 Billion hit to end its involvement with the sale of the drug. Doctoral and patient support, as well as profits, has been too dismal to warrant any kind of extended sale of what was seen as a breakthrough in diabetes management by many.
(READ MORE)
2007 is behind us now. It blurred by and stamped in key moments that will surely be remembered. My past year with diabetes stacks upon only a few others since I was
diagnosed. 2008 will mark four years since that day in the hospital and it seems like I'm always
learning something new. Each highlighted moment in this year taught me a little more about how I successfully live with diabetes.
(READ MORE)